Loading…
Diebold Nixdorf, Incorporated is projected to rise to $102.34 by 2027, a +31% move from its current price of $78.03. DBD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $76.24 | $78.06 | $79.93 | +0.04% |
| May 30 | $75.53 | $78.09 | $80.74 | +0.08% |
| May 31 | $74.99 | $78.12 | $81.38 | +0.12% |
| Jun 1 | $74.54 | $78.15 | $81.93 | +0.15% |
| Jun 2 | $74.16 | $78.18 | $82.42 | +0.19% |
| Jun 3 | $73.81 | $78.21 | $82.87 | +0.23% |
| Jun 4 | $73.50 | $78.24 | $83.29 | +0.27% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $73.50 | $78.24 | $83.29 | +0.27% |
| Week 2 | $71.82 | $78.45 | $85.70 | +0.54% |
| Week 3 | $70.59 | $78.66 | $87.65 | +0.81% |
| Week 4 | $69.61 | $78.88 | $89.38 | +1.08% |
| Week 5 | $68.78 | $79.09 | $90.95 | +1.36% |
| Week 6 | $68.05 | $79.30 | $92.42 | +1.63% |
| Week 7 | $67.40 | $79.52 | $93.81 | +1.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Diebold Nixdorf, Incorporated provides technology solutions that automate, digitize, and transform the way people bank and shop worldwide. The company operates through two segments, Banking and Retail, and offers a range of devices and software to support branch automation, EPOS, self-checkout, and data analytics. In the Banking segment, it manufactures and sells branch automation solutions, including DN Series recyclers, ATMs, cash recycling technology, and the DN Teller Cash Recycler and Dual Tower Recycler, along with multi-vendor service capabilities and DN Vynamic software for enhanced connectivity and analytics.
The Retail segment offers modular and integrated EPOS systems, self-checkout solutions like DN Series EASY ONE and EASY MAX Kiosk, BEETLE POS systems, and the DN Vynamic Retail Platform for digital receipts, rewards, data analysis, and compliance, plus services such as remote device monitoring and advisory services using AI for predictive diagnostics and operational efficiencies. The company also provides integrated core operations supporting security and efficient cash management, with offerings including installation, maintenance, managed services, automation, and data intelligence via the Allconnect data engine. The company was formerly known as Diebold, Incorporated and changed its name to Diebold Nixdorf, Incorporated in December 2016.
Diebold Nixdorf, Incorporated was founded in 1859 and is headquartered in North Canton, Ohio.
Diebold Nixdorf, Incorporated (DBD) trades with a current price of $74.30 and a market capitalization of $2.57B, and it is ranked 1837. The 303-day and broader market context are not provided, but the stock sits in a niche technology and services space focused on banking and retail automation. The forecasted outlook projects a path of upside over the coming years, with higher average prices in later years.
By 2030, the forecast projects an average price of $150.33, and further gains are implied through 2040 and into 2050 with substantial upside.
A major floor 25.0% below — a decisive break under it would weaken the trend.
The nearest floor, 11.9% below — buyers have tended to step in here.
The nearest ceiling, 13.8% above — a clean break opens room to run.
A major ceiling 26.3% above — clearing it would confirm fresh momentum.
Key DBD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DBD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $75.11 | Buy | $75.82 | Buy |
| MA 10 | $72.70 | Buy | $74.86 | Buy |
| MA 20 | $75.40 | Buy | $75.74 | Buy |
| MA 50 | $78.22 | Sell | $76.90 | Buy |
| MA 100 | $75.79 | Buy | $74.89 | Buy |
| MA 200 | $68.69 | Buy | $69.35 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.77 | Neutral |
| Stoch RSI (14) | 88.65 | Sell |
| CCI (20) | 51.91 | Neutral |
| Williams %R (14) | -13.13 | Info |
| MACD (12,26,9) | 0.55 | Buy |
| ROC (12) | 0.03 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 86.87 | Sell |
| TRIX (15) | -0.37 | Sell |
| Awesome (5,34) | -4.27 | Sell |
| Ultimate (7,14,28) | 66.12 | Neutral |
| Momentum (10) | 2.67 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 78.36 | Sell |
| ADX (14) | 21.86 | Buy |
| ATR (14) | 1.70 | Info |
The 30-day technical picture is bullish, with RSI(14) at 50 and the price moving around key averages. The stock trades above the 200-day moving average at $68.50, and below the 50-day moving average at $77.98. Near-term support is at $68.77 and resistance at $88.77, framing a 30-day range between $64.87 and $85.10.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $63.96 | $78.03 | $111.18 | 0% | Neutral | |
| $82.23 | $102.34 | $134.27 | +31% | Bullish | |
| $107.60 | $137.04 | $185.55 | +76% | Bullish | |
| $125.70 | $163.22 | $226.59 | +109% | Bullish | |
| $125.80 | $166.16 | $235.62 | +113% | Bullish | |
| $140.59 | $188.60 | $272.47 | +142% | Bullish | |
| $154.60 | $210.42 | $309.13 | +170% | Bullish | |
| $171.99 | $237.27 | $353.94 | +204% | Bullish | |
| $212.41 | $296.83 | $449.06 | +280% | Bullish | |
| $227.16 | $321.36 | $492.59 | +312% | Bullish | |
| $351.19 | $525.09 | $850.57 | +573% | Bullish | |
| $593.38 | $974.59 | $1,712.26 | +11.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $63.96 | $78.03 | $91.55 | +0.00% |
| June 2026 | $66.78 | $78.20 | $93.57 | +0.22% |
| July 2026 | $68.52 | $80.82 | $97.85 | +3.35% |
| August 2026 | $71.52 | $84.83 | $103.63 | +4.96% |
| September 2026 | $71.65 | $85.38 | $105.07 | +0.65% |
| October 2026 | $70.96 | $84.93 | $105.21 | -0.53% |
| November 2026 | $72.59 | $87.22 | $108.68 | +2.69% |
| December 2026 | $73.59 | $88.74 | $111.18 | +1.74% |
Click any year to see its month-by-month DBD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, DBD is projected to trade between $63.96 and $111.18, averaging $78.03 — a potential gain of 0% from today's $78.03. A consolidation phase looks the most probable path here.
Diebold Nixdorf, Incorporated's 2027 outlook centres on $102.34, within a $82.23 to $134.27 range. That is up +31% on the projected 2026 average. That marks a +31% change versus current levels. Momentum favours further upside here.
By 2028, DBD could reach as high as $185.55, with a base case around $137.04 and support toward $107.60 — roughly +76% from $78.03. Buyers look set to stay in control over this stretch.
Expect DBD to range from $125.70 to $226.59 through 2029. The $163.22 average target implies a +109% move from current prices. That is up +19% on the projected 2028 average. Momentum favours further upside here.
The DBD price prediction for 2030 points to an average of $166.16 (low $125.80, high $235.62) — a potential gain of +113% on today's $78.03. Buyers look set to stay in control over this stretch.
In 2031, DBD is projected to trade between $140.59 and $272.47, averaging $188.60 — a potential gain of +142% from today's $78.03. That is up +14% on the projected 2030 average. Momentum favours further upside here.
Diebold Nixdorf, Incorporated's 2032 outlook centres on $210.42, within a $154.60 to $309.13 range. That is up +12% on the projected 2031 average. That marks a +170% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, DBD could reach as high as $353.94, with a base case around $237.27 and support toward $171.99 — roughly +204% from $78.03. Momentum favours further upside here.
Expect DBD to range from $212.41 to $449.06 through 2034. The $296.83 average target implies a +280% move from current prices. That is up +25% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The DBD price prediction for 2035 points to an average of $321.36 (low $227.16, high $492.59) — a potential gain of +312% on today's $78.03. Momentum favours further upside here.
In 2040, DBD is projected to trade between $351.19 and $850.57, averaging $525.09 — a potential gain of +573% from today's $78.03. That is up +63% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Diebold Nixdorf, Incorporated's 2050 outlook centres on $974.59, within a $593.38 to $1,712.26 range. That is up +86% on the projected 2040 average. That marks a +11.5x change versus current levels. Momentum favours further upside here.
Investing $1,000 in DBD today (≈ 12.815584 DBD) could be worth
$12,489.9
+$11,489.9 (+1149%) by 2050 · US Dollar
Based on the average projected DBD price of $974.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DBDwould be worth at today's price.
$1,000 invested in DBD on May 27, 2025 (≈ 20.508614 DBD) would be worth
$1,600.29
+$600.29 (+60.0%) today · 1.60× · US Dollar
Based on a DBD entry price of $48.76 vs. today's $78.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $71.41 | $1,092.7 | +9.3% |
| 1 month ago | $82.33 | $947.77 | -5.2% |
| 3 months ago | $83.05 | $939.55 | -6.0% |
| 6 months ago | $64.52 | $1,209.39 | +20.9% |
| 1 year ago | $48.76 | $1,600.29 | +60.0% |
| All time (2.8y) ago | $20.57 | $3,793.39 | +279.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DBD forecast.
Our base-case forecast reaches $160.00 around 2029.
Implied market cap at $160.00: $5.54B
The multi-year forecast shows meaningful upside across the 2026–2050 horizon. The 2030 average is projected at $150.33 with a ROI of 102.3% and a bullish sentiment. By 2040 the average is seen at $451.50, with a ROI of 507.7%, underscoring a strong longer-term uptrend.
The 2050 forecast shows an average of $822.56 and a ROI of 1007.1%, reflecting a very wide potential gain if the path plays out as projected. The path includes steadily rising averages from 2027 through 2035, with the 2027–2029 figures also showing solid gains and bullish sentiment. These forecasts are estimates, not guarantees, and actual results will depend on market dynamics and company performance.
Key risks include macroeconomic conditions and competitive pressures that could alter the trajectory of the projected path.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $150.33 with a maximum of $208.24 and a minimum of $115.97, and a return on investment of 102.3% with a bullish sentiment.
Forecasts through 2026–2050 show rising averages and bullish sentiment, with 2030 average $150.33 and ROI 102.3%, 2040 average $451.50 and ROI 507.7%, and 2050 average $822.56 and ROI 1007.1%. These are estimates, not guarantees.
Yes, the 2030 forecast maximum is $208.24, with an average of $150.33 and ROI of 102.3%, and a bullish sentiment.
Current price is $74.30 and market cap is $2.57B.
The 2027 forecast is an average of $95.47 with a minimum of $77.50, a maximum of $123.45, and a ROI of 28.5% with bullish sentiment.
Diebold Nixdorf, Incorporated Community Discussion
0Share your Diebold Nixdorf, Incorporated price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.